SEARCH RESULTS FOR: 立陶宛U卡(www.usdtcard.org)Ms2M(9964 results)

Export results
Company Name Brand Name GMDN Term Name GMDN Term Status FDA Product Code Name FDA Product Code Device Packaged As Sterile Sterilization Prior To Use Issuing Agency Device Size Device Size Type Device Class Implantable

Show Filters

MemoryGel Xtra Moderate High (MHX) Smooth Sizer 185cc
MENTOR TEXAS L.P.
RSZSMHX185S
In Commercial Distribution

  • 10081317027970 ()
RSZ-SMHX-185S

  • Invasive breast implant sizer, fixed, reusable
MemoryGel Xtra Moderate High (MHX) Smooth Sizer 170cc
MENTOR TEXAS L.P.
RSZSMHX170S
In Commercial Distribution

  • 10081317027963 ()
RSZ-SMHX-170S

  • Invasive breast implant sizer, fixed, reusable
MemoryGel Xtra Moderate High (MHX) Smooth Sizer 150cc
MENTOR TEXAS L.P.
RSZSMHX150S
In Commercial Distribution

  • 10081317027956 ()
RSZ-SMHX-150S

  • Invasive breast implant sizer, fixed, reusable
MemoryGel Xtra Moderate High (MHX) Smooth Sizer 130cc
MENTOR TEXAS L.P.
RSZSMHX130S
In Commercial Distribution

  • 10081317027949 ()
RSZ-SMHX-130S

  • Invasive breast implant sizer, fixed, reusable
Intra-Compartmental Pressure Monitor System
STRYKER CORPORATION
0295006000
In Commercial Distribution

  • 34546540052323 ()
  • 04546540052322 ()
0295006000

  • Compartmental-pressure monitoring system, single-use
Side-Ported Needle
STRYKER CORPORATION
0295003000
In Commercial Distribution

  • 34546540052316 ()
  • 04546540052315 ()

  • Length: 2.4 Inch
  • Needle Gauge: 18.0 Gauge
0295003000

  • Compartmental-pressure monitoring system, single-use
The Lacriflow CL is indicated in treatments of epiphora in patients 12 months and older, in cases of: - Canalicular pathologies (stenosis, obstruction, lacerations), - During Dacryocystorhinostomy (conventional or laser), - Congenital nasolacrimal duct obstruction.
KANEKA CORPORATION
LF-CL090A
In Commercial Distribution

  • 14540778171395 ()
  • 04540778171398 ()

  • Length: 90 Millimeter


  • Lacrimal tube
The Lacriflow CL is indicated in treatments of epiphora in patients 12 months and older, in cases of: - Canalicular pathologies (stenosis, obstruction, lacerations), - During Dacryocystorhinostomy (conventional or laser), - Congenital nasolacrimal duct obstruction.
KANEKA CORPORATION
LF-CL105A
In Commercial Distribution

  • 04540778171381 ()
  • 14540778171388 ()

  • Length: 105 Millimeter


  • Lacrimal tube
The LACRIFLOW is indicated in treatments of epiphora in-patients 12 months and older, in cases of: - Canalicular pathologies (stenosis, obstruction, lacerations), - During Dacryocystorhinostomy (conventional or laser), - Congenital nasolacrimal duct obstruction.
KANEKA CORPORATION
LF-R090A
In Commercial Distribution

  • 04540778140875 ()
  • 14540778140872 ()

  • Length: 90 Millimeter


  • Lacrimal tube
The LACRIFLOW is indicated in treatments of epiphora in-patients 12 months and older, in cases of: - Canalicular pathologies (stenosis, obstruction, lacerations), - During Dacryocystorhinostomy (conventional or laser), - Congenital nasolacrimal duct obstruction.
KANEKA CORPORATION
LF-R105A
In Commercial Distribution

  • 04540778140868 ()
  • 14540778140865 ()

  • Length: 105 Millimeter


  • Lacrimal tube
< 1 ... 370 371 372 373 374 ... 997 >